Relationship Between Oral DMT Burden and Adherence in MS
Conditions: Multiple Sclerosis; Adherence, Medication Interventions: Drug: Cladribine; Drug: Dimethyl fumarate; Drug: Fingolimod; Drug: Teriflunomide Sponsor: Monash University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2020 Category: Research Source Type: clinical trials
Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke II (FAMTAIS II)
Conditions: Stroke; Inflammation Interventions: Drug: Fingolimod; Other: Placebo Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2020 Category: Research Source Type: clinical trials
Relationship Between Oral DMT Burden and Adherence in MS
Conditions: Multiple Sclerosis; Adherence, Medication Interventions: Drug: Cladribine; Drug: Dimethyl fumarate; Drug: Fingolimod; Drug: Teriflunomide Sponsor: Monash University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2020 Category: Research Source Type: clinical trials
Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke II (FAMTAIS II)
Conditions: Stroke; Inflammation Interventions: Drug: Fingolimod; Other: Placebo Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2020 Category: Research Source Type: clinical trials
Relationship Between Oral DMT Burden and Adherence in MS
Conditions: Multiple Sclerosis; Adherence, Medication Interventions: Drug: Cladribine; Drug: Dimethyl fumarate; Drug: Fingolimod; Drug: Teriflunomide Sponsor: Monash University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2020 Category: Research Source Type: clinical trials
Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke II (FAMTAIS II)
Conditions: Stroke; Inflammation Interventions: Drug: Fingolimod; Other: Placebo Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2020 Category: Research Source Type: clinical trials
Relationship Between Oral DMT Burden and Adherence in MS
Conditions: Multiple Sclerosis; Adherence, Medication Interventions: Drug: Cladribine; Drug: Dimethyl fumarate; Drug: Fingolimod; Drug: Teriflunomide Sponsor: Monash University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2020 Category: Research Source Type: clinical trials
Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke II (FAMTAIS II)
Conditions: Stroke; Inflammation Interventions: Drug: Fingolimod; Other: Placebo Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2020 Category: Research Source Type: clinical trials
Relationship Between Oral DMT Burden and Adherence in MS
Conditions: Multiple Sclerosis; Adherence, Medication Interventions: Drug: Cladribine; Drug: Dimethyl fumarate; Drug: Fingolimod; Drug: Teriflunomide Sponsor: Monash University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2020 Category: Research Source Type: clinical trials
Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients
Condition: Relapsing Multiple Sclerosis (RMS) Intervention: Drug: Fingolimod 0.5mg Sponsor: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2020 Category: Research Source Type: clinical trials
